An international symposium bringing together leading neuroscience experts to share the latest advances in research, diagnosis, and treatment of Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD).
Join ferrer at Neuro 2026
Ferrer Scientific contribution
Ferrer has been invited to contribute to a round-table session on clinical trials, sharing perspectives from our experience in PSP clinical-trial recruitment and collaboration with patient advocacy groups
Join the scientific conversation
Industry Perspectives and Clinical Trials
- Date: Thursday, 5 November 2026
- Time: 1:15 – 2:45 PM (GMT)
- Session Chair: Kristophe Diaz - CurePSP Chief Executive Officer, New York, USA
As part of this round table, Ferrer will participate in the following session:
Making Engagement Count: Partnering with the PSP Community in Clinical Development – Lessons Learned from Ferrer’s Partnership with PSP Advocacy Groups
Thursday, 5 November 2026 · 1:30 – 1:45 PM (GMT)
PSP Glossary
Key PSP definitions and concepts developed to better understand its terminology and navigate it with more confidence.
Watch: PSP & FNP-223 MoA
Play this short video to delve deeper into the pathophysiology of PSP and the mechanism of action of FNP-223.
AXONIA - Accredited webinar series
Meet Axonia, a four-part expert-led webinar series on rare neurodegenerative diseases. An exclusive space designed to educate, update, and connect neurologists and specialists who aim to transform knowledge into real patient impact. Register here to access the Axonia session on Progressive Supranuclear Palsy. Avaiable on demand
- Hidden Signs – Tauopathies & Early Movement Disorder Feature
